Recurrent peritonitis in a patient on dialysis and prophylactic vancomycin

Lancet

Volumn 351, Issue 9106, 1998, Pages 880-881

  Sieradzki, Krzysztof ^b   Roberts, Richard B ^b   Serur, David ^b   Hargrave, Judie ^b   Tomasz, Alexander ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

VANCOMYCIN;

ADULT; BACTERIUM CULTURE; CASE REPORT; CATHETER INFECTION; ENTEROCOCCUS FAECALIS; FEMALE; HUMAN; INTRAPERITONEAL DRUG ADMINISTRATION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PERITONEAL DIALYSIS; PERITONITIS; PRIORITY JOURNAL; RECURRENT INFECTION; SHORT SURVEY;

EID: 0032554542     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)70291-9     Document Type: Article

References (5)

1. 1 Sieradzki K, Villari P, Tomasz A. Decreased susceptibilities to teicoplanin and vancomycin among coagulase-negative methicillin-resistant clinical isolates of staphylococci. Antimicrob Agents Chemother 1998; 42: 100-07.
2. 2 Sieradzki K, Tomasz A. Inhibition of cell wall turnover and autolysis by vancomycin in a highly vancomycin-resistant mutant of Staphylococcus aureus. J Bacteriol 1997; 179: 2557-66.
3. 3 Sanyal D, Greenwood D. An electronmicroscope study of glycopeptide antibiotic-resistant strains of Staphylococcus epidermidis. J Med Microbiol 1993; 39: 204-10.
4. 4 Hiramatsu K, Hanaki H, Ino T, Yabuta K, Oguri T, Tenover FC. Methicillin resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J Antimicrob Chemother 1997; 40: 135-36.
5. 5 Centers for Disease Control. Staphylococcus aureus with reduced susceptibility to vancomycin - United States, 1997. Morbid Mortal Weekly Rep 1997; 46: 765-66.